Scarica l'app Stockscreener
321.50
1.39%
-4.53
Precedente Chiudi:
$326.03
Aprire:
$326.14
Volume 24 ore:
175.56K
Relative Volume:
0.37
Capitalizzazione di mercato:
$8.79B
Reddito:
$2.16B
Utile/perdita netta:
$416.39M
Rapporto P/E:
24.54
EPS:
13.1
Flusso di cassa netto:
$540.93M
1 W Prestazione:
+4.79%
1M Prestazione:
+5.04%
6M Prestazione:
-5.29%
1 anno Prestazione:
-20.24%
Intervallo 1D:
$320.03
$329.54
Intervallo di 1 settimana:
$306.95
$329.54
Portata 52W:
$250.05
$459.77
Medpace Holdings Inc Stock (MEDP) Company Profile
Nome
Medpace Holdings Inc
Settore
Industria
Telefono
(513) 579-9911
Indirizzo
5375 MEDPACE WAY, CINCINNATI, OH
Confronta MEDP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
321.50 | 8.79B | 2.16B | 416.39M | 540.93M | 13.10 |
|
TMO
Thermo Fisher Scientific Inc
|
429.33 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
203.20 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
547.01 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
121.38 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.24 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-24 | Iniziato | Leerink Partners | Market Perform |
| 2024-10-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-27 | Downgrade | UBS | Buy → Neutral |
| 2024-09-25 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-01 | Iniziato | Truist | Hold |
| 2024-05-29 | Iniziato | TD Cowen | Buy |
| 2024-05-28 | Iniziato | Mizuho | Buy |
| 2024-04-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-18 | Iniziato | Deutsche Bank | Hold |
| 2024-02-15 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-27 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-07 | Iniziato | UBS | Sell |
| 2022-05-24 | Iniziato | Guggenheim | Neutral |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-10-02 | Aggiornamento | Truist | Hold → Buy |
| 2020-06-08 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Aggiornamento | SunTrust | Sell → Hold |
| 2020-04-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Downgrade | SunTrust | Hold → Sell |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2018-10-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-09-17 | Iniziato | SunTrust | Hold |
| 2018-07-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2017-07-10 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Medpace Holdings Inc Borsa (MEDP) Ultime notizie
Medpace (MEDP) Dips More Than Broader Market: What You Should Know - Nasdaq
Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 48% Discount? - simplywall.st
Medpace: An Excellent Company In A Context Of Uncertainty (NASDAQ:MEDP) - Seeking Alpha
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
truist securities maintains hold rating on medpace stock By Investing.com - Investing.com Canada
truist securities maintains hold rating on medpace stock - Investing.com
Why Medpace Holdings Shares Are Under Pressure - TipRanks
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
Is Medpace Stock Worth the Hype? Here's What Analysts Think. - AOL.com
Is Medpace Stock Worth The Hype? Here's What Analysts Think. - Barchart.com
Investing in Medpace Holdings (NASDAQ:MEDP) five years ago would have delivered you a 211% gain - simplywall.st
Deutsche Bank AG Sells 5,583 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Insider Monkey
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
William Blair Remains a Hold on Medpace Holdings (MEDP) - The Globe and Mail
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Rating of “Hold” from Analysts - Defense World
Medpace Holdings Approves Key Proposals at Annual Meeting - TipRanks
RNA Therapy Clinical Trials Market Top Companies StudyCharles - openPR.com
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Medpace Holdings Surpasses Expectations with Q1 2025 EarningsNews and Statistics - IndexBox
MEDP STOCK ALERT: Levi & Korsinsky Notifies Medpace Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)? - Yahoo Finance
Medpace Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking - simplywall.st
Hsbc Holdings PLC Has $566,000 Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN
Positive Long-Term Outlook for Narrow-Moat Medpace Despite Macroeconomic Pressure in Near Term - Morningstar
Press Release Distribution & PR Platform - ACCESS Newswire
Medpace (MEDP) Faces Earnings Volatility Amid Tariff Concerns - GuruFocus
Medpace drops despite Q1 beat amid disappointing performance metrics - MSN
William Blair Issues Negative Outlook for Medpace Earnings - Defense World
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus
William Blair Forecasts Medpace’s Q3 Earnings (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript - MSN
Medpace to increase size of stock buyback program by $1B - MSN
William Blair Downgrades Medpace Holdings (BMV:MEDP) - Nasdaq
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Ho - GuruFocus
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus
Truist Cuts Price Target on Medpace Holdings to $300 From $333, Keeps Hold Rating - marketscreener.com
Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outloo - GuruFocus
Medpace Holdings Inc Azioni (MEDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medpace Holdings Inc Azioni (MEDP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DAVENPORT FRED B JR | Director |
Apr 24 '25 |
Sale |
301.82 |
1,712 |
516,716 |
2,998 |
0.18%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):